CircRIP2, low expressed in bladder cancer, has been demonstrated to have effects on suppression of tumor progression when circRIP2 binds to miR-1305 to enhance TGF-β2 and induces EMT via the TGF-β2/Smad3 pathway (Su et al. 2020). The gene discussed is TGFB2; the disease is urinary bladder cancer.